lipid synthesis

4-Hydroxyflavanone is a natural product, shows full vasorelaxing effects

DBIBB is a non-lipid agonist of specific lysophosphatidic acid (LPA2) type 2 G-protein-coupled receptor. It is a potentially active molecule for the treatment of acute radiation syndrome caused by high intensity gamma rays on hematopoietic and gastrointestinal systems. It is an intermediate in organic synthesis and drug research. DBIBB can be used to prepare various compounds that reduce gastrointestinal radiation syndrome, increase intestinal crypt survival and intestinal cell proliferation, and reduce cell apoptosis.

Lifibrol (U-83860) is an inhibitor of cholesterol synthesis.Lifibrol has anticholesterol and hypolipidemic properties and promotes the conversion of LDL Apo B-100 in patients with hypercholesterolemia and mixed hyperlipidemia.

Uridine 5'-monophosphate disodium salt (Disodium UMP) has been used to study the effect of pyrimidine synthesis inhibitor, 5-azacytidine, on cholesterol and lipid metabolism. It has been used to study the effect of nucleotides on growth of specific intestinal bacteria.

Cyclohexane-1,2,3,4,5,6-hexaol, also known as inositol, is a natural cyclohexane derivative and alcohol compound with biological activity in signal transduction, osmotic pressure regulation, and lipid metabolism, and is widely used in biochemical experiments and drug synthesis research.

Beauveriolide III, a cyclodepsipeptide found in Beauveria fungi, inhibits lipid droplet formation (at 3-10 μM) and cholesterol synthesis (IC50=0.41 μM). This compound also suppresses acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity (IC50=5.5 μM) and reduces atherosclerotic lesion size in Ldlr-/- and ApoE-/- mouse models (25-50 mg/kg).

Broussochalcone A is a natural antioxidant and xanthine oxidase inhibitor (IC50 = 2.21 μM) that scavenges free radicals, inhibits iron-induced lipid peroxidation, and reduces nitric oxide synthesis in LPS-activated macrophages. Broussochalcone A induces apoptosis in human renal carcinoma cells by increasing ROS levels and activating the FOXO3 signaling pathway. Broussochalcone A is also a novel NR4A1 inhibitor that induces apoptosis in pancreatic cancer cells through NR4A1-dependent pathways.

G0-C14 HCl is the salt form of G0-C14, a cationic lipid molecule and amphiphilic dendritic macromolecule commonly used in the synthesis of nanoparticles and vaccine delivery.

Hydrocarbon chain derivative 1 has inhibitory activities against lipid synthesis.

Leelamine hydrochloride, a tricyclic diterpene extracted from pine tree bark, inhibits the transcriptional activity of the androgen receptor, known to regulate fatty acid synthesis [2,3]. This compound acts as a cannabinoid receptor type 1 (CB1) agonist and suppresses SREBP1-regulated fatty acid/lipid synthesis in prostate cancer cells, irrespective of androgen receptor status.

(±)15-HETE is an eicosanoid compound that possesses intrinsic biological activities and serves as a key enzymatic precursor for the biosynthesis of numerous other biologically active lipid-derived derivatives; furthermore, this alkyl chain-based structure functions as a proteolysis-targeting chimera (PROTAC) linker utilized in the chemical synthesis of various PROTAC molecules designed for targeted protein degradation.

Cyhalofop-butyl is an ACCase (acetyl-coenzyme A carboxylase) inhibitor and herbicide that suppresses plant lipid synthesis at the meristematic level.

ZLY06 is a dual agonist of peroxisome proliferator-activated receptors (PPAR) δ and γ with oral activity (PPAR δ: EC50=341 nM; PPARγ: EC50=237 nM). It mediates the upregulation of CD36 and induces hepatic lipid accumulation by inhibiting the phosphorylation of AKT1. Moreover, ZLY06 significantly improves glucose and lipid metabolism without increasing body weight, primarily by enhancing the β-oxidation of fatty acids and reducing hepatic lipid synthesis, thereby alleviating fatty liver disease.

CL15F6 is an ionizable lipid used in the synthesis of lipid nanoparticles (LNP) for the delivery of mRNA and other effective payloads.

Lipid 16 is an ionizable lipid that facilitates the synthesis of lipid nanoparticles (LNP) for the delivery of mRNA and other payloads. It specifically targets the CD11bhi macrophage population as a potent cell-type specific ionizable lipid, eliminating the need for additional targeting components.

IM21.7c is a cationic lipid utilized in the synthesis of lipid nanoparticles (LNP) for the delivery of mRNA and other effective payloads.

C14-A1 is an ionizable cationic lipid utilized in the synthesis of lipid nanoparticles (LNP), which are employed for delivering mRNA and various other payloads.

CAP2 (Cholesterol-amino-phosphate 2) hydrochloride is a lipid within the cholesterol amino phosphate (CAP) family. It is employed in the synthesis of lipid nanoparticles (LNP) for the delivery of mRNA and other efficacious payloads.

C14-O2 is an ionizable cationic lipid utilized in the synthesis of lipid nanoparticles (LNP) for the delivery of mRNA and other payloads.

LW1564 is an HIF-1α inhibitor with an IC50 of 1.2 µM in HepG2 cells. It suppresses mitochondrial respiration, reduces ATP production, and stimulates HIF-1α degradation, thereby inhibiting the proliferation of various cancer cells with a GI50 ranging from 0.4 to 4.6 μM. Additionally, LW1564 activates the AMPK signaling pathway and inhibits lipid synthesis. In HepG2 xenograft mouse models, LW1564 demonstrates antitumor activity.

Cardiolipin (16:0/18:1/16:0/18:1) (16:0-18:1 Cardiolipin) sodium is an anionic phospholipid composed of long-chain fatty acid palmitic acid and monounsaturated fatty acid oleic acid. This compound can be utilized in the synthesis of nanodisk lipid bilayers for in situ mass spectrometry applications.

Lipid A6 is a biodegradable alkyne lipid used in the synthesis of lipid-like nanoparticles (LNPs) for mRNA delivery.

Lipid C3 can be utilized in the synthesis of lipid-like nanoparticles (LNPs) for mRNA delivery.

Lipid A-11 is a lipid component of endotoxin that is primarily responsible for the toxic properties of gram-negative bacteria. Lipid A-11 constitutes the innermost region of the lipopolysaccharide (LPS) molecule, also known as endotoxin, and its hydrophobic nature facilitates anchoring of the LPS structure into the bacterial outer membrane. Lipid A-11 plays a critical role in host-pathogen interactions, contributing to septic shock and immunological activation during bacterial infections.